Alembic Ltd

Alembic Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Alembic Ltd

₹ 116 -3.15%
13 Jun - close price
alembiclimited.com BSE: 506235 NSE: ALEMBICLTD
About

Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.
With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]

Key Points

Business Segments
A) Real Estate (~80% in FY24 vs 59% in FY22): [1] [2] The company is involved in the construction of residential & commercial real estate projects. It also leases commercial properties. [3] Real Estate business experienced strong growth between FY23-FY24 bolstered by strong demand and higher property prices. [4]

Website BSE NSE
  • Market Cap ₹ 2,970 Cr.
  • Current Price ₹ 116
  • High / Low ₹ 169 / 85.5
  • Stock P/E 9.56
  • Book Value ₹ 91.1
  • Dividend Yield 2.08 %
  • ROCE 6.95 %
  • ROE 13.7 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 24.1%

Cons

  • Tax rate seems low
  • Company has a low return on equity of 11.6% over last 3 years.
  • Earnings include an other income of Rs.74.9 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Realty Realty Residential, Commercial Projects

Part of BSE SmallCap BSE Allcap BSE Consumer Discretionary

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
18 22 37 31 37 37 32 39 49 51 53 58 60
15 17 26 20 24 26 22 28 25 30 33 32 33
Operating Profit 3 5 11 10 13 11 10 12 24 20 20 26 27
OPM % 16% 25% 30% 34% 36% 30% 31% 30% 49% 40% 37% 46% 45%
4 1 59 2 -9 3 48 2 2 2 66 4 3
Interest 0 0 0 0 0 0 0 0 0 0 1 1 1
Depreciation 1 2 2 2 2 2 2 3 1 2 3 3 3
Profit before tax 6 4 68 11 3 12 56 11 24 19 82 27 27
Tax % 20% 11% 10% 2% -55% 14% 8% 9% 12% 10% 6% 5% 12%
1 -19 115 46 48 44 91 61 72 56 121 65 68
EPS in Rs 0.04 -0.72 4.49 1.78 1.88 1.73 3.53 2.39 2.81 2.17 4.71 2.55 2.67
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,121 144 134 147 125 124 74 74 78 127 157 222
1,018 134 128 140 114 106 71 62 64 87 101 128
Operating Profit 103 10 6 7 11 18 3 11 14 40 57 94
OPM % 9% 7% 5% 5% 9% 15% 4% 15% 18% 32% 36% 42%
16 21 25 25 37 29 93 10 89 54 55 75
Interest 32 1 0 0 0 0 0 0 0 0 1 2
Depreciation 43 6 6 5 4 3 3 4 5 7 8 11
Profit before tax 44 23 25 27 44 45 93 17 98 87 103 156
Tax % 10% -3% 2% -3% 5% 8% 0% 19% 12% 7% 10% 7%
40 107 235 145 163 213 329 343 222 191 269 311
EPS in Rs 1.48 3.99 8.78 5.45 6.10 8.30 12.82 13.35 8.65 7.42 10.46 12.10
Dividend Payout % 17% 4% 2% 4% 3% 2% 5% 2% 21% 30% 23% 20%
Compounded Sales Growth
10 Years: 4%
5 Years: 25%
3 Years: 42%
TTM: 41%
Compounded Profit Growth
10 Years: 11%
5 Years: -1%
3 Years: 12%
TTM: 16%
Stock Price CAGR
10 Years: 15%
5 Years: 7%
3 Years: 24%
1 Year: 12%
Return on Equity
10 Years: 15%
5 Years: 12%
3 Years: 12%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 27 53 53 53 53 51 51 51 51 51 51 51
Reserves 311 474 750 858 1,032 1,157 1,367 2,246 2,445 2,027 2,134 2,287
408 0 9 0 0 0 0 0 0 0 9 14
251 91 64 81 73 57 53 112 135 127 134 150
Total Liabilities 997 619 875 992 1,159 1,266 1,471 2,409 2,632 2,205 2,329 2,503
393 169 146 171 179 209 225 265 297 321 369 409
CWIP 4 2 0 0 0 0 3 6 0 0 1 0
Investments 8 299 605 732 913 1,001 1,133 2,047 2,208 1,754 1,786 1,900
591 149 124 89 67 55 110 91 127 130 173 194
Total Assets 997 619 875 992 1,159 1,266 1,471 2,409 2,632 2,205 2,329 2,503

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
149 22 10 52 24 22 7 -2 -18 39 23 86
-24 5 -5 -47 -22 68 57 -35 19 7 26 -27
-118 -25 -5 -5 -3 -89 -6 -15 -6 -46 -48 -58
Net Cash Flow 7 2 -0 -0 -1 1 57 -52 -5 -0 0 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 63 122 76 54 74 40 44 69 71 67 46 49
Inventory Days 158 880 659 438 247 289 411 2,112 2,885 3,694 525
Days Payable 128 200 144 128 125 202 151 693 640 1,237 149
Cash Conversion Cycle 93 801 591 364 195 126 305 1,488 2,316 67 2,502 425
Working Capital Days 108 235 172 39 20 13 22 98 223 118 81 154
ROCE % 10% 4% 4% 4% 4% 7% 1% 4% 4% 5% 7%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88%
1.08% 0.83% 0.82% 0.70% 0.72% 0.85% 0.89% 1.07% 1.42% 1.97% 1.78% 1.65%
4.29% 4.12% 3.94% 3.94% 3.93% 3.40% 0.04% 0.04% 0.04% 0.08% 0.06% 0.05%
23.75% 24.16% 24.34% 24.48% 24.46% 24.87% 28.17% 28.02% 27.66% 27.07% 27.27% 27.41%
No. of Shareholders 83,00683,61283,63082,33981,73282,94794,01299,13098,4781,02,2491,07,4231,06,732

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings